CSL Limited
CSLLY | OTC
$31.91
+$0.81 (+2.60%)
At close: Sep 21, 2026, 3:59 PM ET
$31.91
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:00 PM ET
Company Profile
No company profile available.
Key Executives
No executive data available
Contact Details
n/a
n/a
Stock Details
| Ticker Symbol | CSLLY |
| Exchange | n/a |
| Fiscal Year | n/a |
| Reporting Currency | n/a |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | n/a |
| SIC Code | n/a |
Recent News
- 12 days ago / prnewswire.comLancet Publication Marks Important Advance in Influenza Prevention for Older Adults
- 21 days ago / zacks.comTrump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized Drugmakers
- 22 days ago / cnbc.comTrump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakers
- 1 month ago / seekingalpha.comCSL Limited (CSLLY) Q4 2026 Earnings Call Transcript
- 1 month ago / reuters.comAustralia's CSL reports 2% fall in annual profit
- 2 months ago / zacks.comCSL Q2 Earnings Beat Estimates on Record Sales, Outlook Raised
- 2 months ago / reuters.comCSL to start clinical trials for new immunoglobulin manufacturing process
- 2 months ago / prnewswire.comCSL Reports Positive Top-Line Phase 3b Results Supporting Planned Expanded Pediatric Filing for ANDEMBRY® (garadacimab-gxii) in Children with Hereditary Angioedema (HAE)
- 3 months ago / prnewswire.comCHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union
- 11 months ago / seekingalpha.comCSL Limited (CSLLY) Shareholder/Analyst Call Transcript
Add to Watchlist
Select watchlists to add or remove CSLLY